InsiderClue
Insiders · Profile

Woiwode Thomas

Director at Tempest Therapeutics · Director at Aligos Therapeutics · Director at Passage BIO · and 1 more. Filing since 24 Oct 2016. CIK 0001619294

TPST Tempest Therapeutics, Inc. Director · 1 trade ALGS Aligos Therapeutics, Inc. Director · 1 trade PASG Passage BIO, Inc. Director · 1 trade CRSP CRISPR Therapeutics AG Director · 12 trades
Company
Date
Role
Action
Shares
Amount
Of holding
TPST Tempest Therapeutics, Inc.
29 Apr 2022
Director
Bought
2,118,644
$5.00M
opened
ALGS Aligos Therapeutics, Inc.
20 Oct 2020
Director
Bought
200,000
$3.00M
30.2%
PASG Passage BIO, Inc.
3 Mar 2020
Director
Bought
225,000
$4.05M
31.8%
CRSP CRISPR Therapeutics AG
15 May 2018
Director
Sold, plan not stated
44,000
$2.55M
6.4%
CRSP CRISPR Therapeutics AG
8 May 2018
Director
Sold, plan not stated
1,653
$85.05K
22.7%
CRSP CRISPR Therapeutics AG
7 May 2018
Director
Sold, plan not stated
119,709
$6.03M
77.4%
CRSP CRISPR Therapeutics AG
30 Apr 2018
Director
Sold, plan not stated
30,566
$1.54M
44.5%
CRSP CRISPR Therapeutics AG
27 Apr 2018
Director
Sold, plan not stated
11,648
$582.66K
23.1%
CRSP CRISPR Therapeutics AG
26 Apr 2018
Director
Sold, plan not stated
210,610
$10.55M
84.3%
CRSP CRISPR Therapeutics AG
24 Apr 2018
Director
Sold, plan not stated
22,841
$1.16M
33.9%
CRSP CRISPR Therapeutics AG
23 Apr 2018
Director
Sold, plan not stated
101,994
$5.17M
69.3%
CRSP CRISPR Therapeutics AG
22 Dec 2017
Director
Sold, plan not stated
3,059
$62.07K
38.2%
CRSP CRISPR Therapeutics AG
27 Nov 2017
Director
Sold, plan not stated
200
$4.05K
2.4%
CRSP CRISPR Therapeutics AG
24 Nov 2017
Director
Sold, plan not stated
1,700
$34.36K
17.1%
CRSP CRISPR Therapeutics AG
24 Oct 2016
Director
Bought
161,000
$2.25M
4.1%
15 decisions on file.